• Filter by age:
  • all adults (15-64) |
  • young adults (15–34) |
  • youngest adults (15–24)
• Filter by gender:
  • females |
  • males
• Filter by prevalence:
  • last 30 days |
  • lifetime |
  • last 12 months
• Filter by drug type:
  • amphetamines |
  • cannabis |
  • cocaine |
  • ecstasy

Statistics found here the category is General population surveys of drug use (GPS) and where the keyword is LTP

Category	Title
GPS	GPS-18. Overview of drug prevalence estimates from various studies in Europe for all adults (aged 15 to 64) and young adults (aged 15 to 34) Part (i) Cannabis use — lifetime experience, last 12 months and last 30 days prevalence
GPS	GPS-18. Overview of drug prevalence estimates from various studies in Europe for all adults (aged 15 to 64) and young adults (aged 15 to 34) Part (ii) Cocaine, amphetamines and ecstasy use — lifetime experience, last 12 months and last 30 days prevalence
GPS	GPS-20. Lifetime and last 12 months prevalence of cocaine use among young adults (aged 15 to 34) in Europe, Canada, Australia and the USA — last survey available for each country
GPS	GPS-1. Lifetime prevalence of drug use in nationwide surveys among the general population: last survey available for each Member State (from 2000 onwards) Part (i) Survey methods: last survey available for each Member State (from 2000 onwards)
GPS	GPS-1. Lifetime prevalence of drug use in nationwide surveys among the general population: last survey available for each Member State (from 2000 onwards) Part (ii) Lifetime prevalence all adults: last survey available for each Member State (from 2000 onwards)
GPS	GPS-1. Lifetime prevalence of drug use in nationwide surveys among the general population: last survey available for each Member State (from 2000 onwards) Part (iii) Lifetime prevalence young adults: last survey available for each Member State (from 2000 onwards)
GPS	GPS-1. Lifetime prevalence of drug use in nationwide surveys among the general population: last survey available for each Member State (from 2000 onwards) Part (iv) Lifetime prevalence 15 to 24 years old: last survey available for each Member State (from 2000 onwards)
GPS	GPS-4. Lifetime prevalence of drug use by gender in nationwide surveys among the general population: last survey available for each Member State (from 2000 onwards) Part (i) Lifetime prevalence all adults males: last survey available for each Member State (from 2000 onwards)
GPS	GPS-4. Lifetime prevalence of drug use by gender in nationwide surveys among the general population: last survey available for each Member State (from 2000 onwards) Part (ii) Lifetime prevalence all adults females: last survey available for each Member State (from 2000 onwards)
GPS	GPS-4. Lifetime prevalence of drug use by gender in nationwide surveys among the general population: last survey available for each Member State (from 2000 onwards) Part (iii) Lifetime prevalence young adults males: last survey available for each Member State (from 2000 onwards)
GPS	GPS-4. Lifetime prevalence of drug use by gender in nationwide surveys among the general population: last survey available for each Member State (from 2000 onwards) Part (iv) Lifetime prevalence young adults females: last survey available for each Member State (from 2000 onwards)
GPS	GPS-4. Lifetime prevalence of drug use by gender in nationwide surveys among the general population: last survey available for each Member State (from 2000 onwards) Part (v) Lifetime prevalence 15 to 24 years old males: last survey available for each Member State (from 2000 onwards)
GPS	GPS-4. Lifetime prevalence of drug use by gender in nationwide surveys among the general population: last survey available for each Member State (from 2000 onwards) Part (vi) Lifetime prevalence 15 to 24 years old females: last survey available for each Member State (from 2000 onwards)
GPS	GPS-7. Lifetime prevalence of drug use in nationwide surveys among the general population Part (i) Survey methods: all surveys
GPS	GPS-7. Lifetime prevalence of drug use in nationwide surveys among the general population Part (ii) Lifetime prevalence all adults: all surveys
GPS	GPS-7. Lifetime prevalence of drug use in nationwide surveys among the general population Part (iii) Lifetime prevalence young adults: all surveys
GPS	GPS-7. Lifetime prevalence of drug use in nationwide surveys among the general population Part (iv) Lifetime prevalence 15 to 24 years old: all surveys